Serum proteomics screening intercellular adhesion molecule-2 improves intermediate-risk stratification in acute myeloid leukemia.
Nan ZhangXiaoyan LiuJinxian WuXinqi LiQian WangGuopeng ChenLinlu MaSanyun WuFuling ZhouPublished in: Therapeutic advances in hematology (2022)
The inclusion of ICAM2 expression into the AML risk classification according to ELN-2017 was a good way to transfer patients from three to two groups. Thus, providing more information for clinical decision-making to improve intermediate-risk stratification in AML patients.
Keyphrases
- end stage renal disease
- chronic kidney disease
- ejection fraction
- acute myeloid leukemia
- peritoneal dialysis
- decision making
- prognostic factors
- poor prognosis
- mass spectrometry
- machine learning
- escherichia coli
- patient reported outcomes
- pseudomonas aeruginosa
- staphylococcus aureus
- binding protein
- cystic fibrosis
- health information
- long non coding rna
- allogeneic hematopoietic stem cell transplantation
- biofilm formation
- candida albicans
- cell adhesion